Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Kost

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Virology|May 10, 1995
Varicella-zoster virus gene 63: transcript mapping and regulatory activityR G Kost, H Kupinsky, S E Straus
Journal of Acquired Immune Deficiency Syndromes (1999)|April 24, 2001
Open-label phase II trial of amprenavir, abacavir, and fixed-dose zidovudine/lamivudine in newly and chronically HIV-1--infected patientsR G Kost, A Hurley, L Zhang, et al.
Lancet (London, England)|June 11, 1994
Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpesS E Straus, L Corey, R L Burke, et al.
The Journal of Infectious Diseases|November 14, 1997
Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: results of a placebo-controlled vaccine trialS E Straus, A Wald, R G Kost, et al.
Antiviral Research|January 1, 1997
Assessment of pain in herpes zoster: lessons learned from antiviral trialsR H Dworkin, D Carrington, A Cunningham, et al.
Travel Medicine and Infectious Disease|October 30, 2016
Differences in prevalence of community-associated MRSA and MSSA among U.S. and non-U.S. born populations in six New York Community Health CentersN Piper Jenks, M Pardos de la Gandara, B M D'Orazio, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Virology|May 10, 1995
Varicella-zoster virus gene 63: transcript mapping and regulatory activityR G Kost, H Kupinsky, S E Straus
Journal of Acquired Immune Deficiency Syndromes (1999)|April 24, 2001
Open-label phase II trial of amprenavir, abacavir, and fixed-dose zidovudine/lamivudine in newly and chronically HIV-1--infected patientsR G Kost, A Hurley, L Zhang, et al.
Lancet (London, England)|June 11, 1994
Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpesS E Straus, L Corey, R L Burke, et al.
The Journal of Infectious Diseases|November 14, 1997
Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: results of a placebo-controlled vaccine trialS E Straus, A Wald, R G Kost, et al.
Antiviral Research|January 1, 1997
Assessment of pain in herpes zoster: lessons learned from antiviral trialsR H Dworkin, D Carrington, A Cunningham, et al.
Travel Medicine and Infectious Disease|October 30, 2016
Differences in prevalence of community-associated MRSA and MSSA among U.S. and non-U.S. born populations in six New York Community Health CentersN Piper Jenks, M Pardos de la Gandara, B M D'Orazio, et al.
Pageof 1